(Exenatide is FDA approved as monotherapy for the management of T2DM.) Explicitly stated in the guideline for patients requiring dual or triple therapy, the AACE/ACE preferentially recommends the addition of a GLP-1 receptor agonist or a DPP-4 inhibitor (sitagliptin, saxagliptin), citing their efficacy and safety profiles as preferred agents over TZDs or sulfonylureas (SUs)
10.1016/j.mehy.2017.12.029 [DOI] [PubMed] 20.Robert SA, Rohana AG, Shah SA, Chinna K, Wan WN, Mohamud, Kamaruddin NA (2015) Improvement in binge-eating in non-diabetic obese individuals after 3 months of treatment with liraglutidea pilot study
Some studies have also shown the presence of GLP-1Rs in mood-related brain regions and demonstrated its powerful role in emotional processing within the CNS (Merchenthaler et al., 1999
Amphetamines are phenethylamine derivatives
GLP-1 (glucagon-like peptide-1) is a hormone that plays a crucial role in regulating blood sugar levels and appetite
If your GLP-1 medication is prescribed for a Part D-covered indication, your Medicare Advantage drug plan may still provide coverage according to its formulary and prior authorization requirements
